These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis. Robb TA; Davidson GP; Kirubakaran C Gut; 1985 Nov; 26(11):1246-56. PubMed ID: 4065698 [TBL] [Abstract][Full Text] [Related]
6. Fetal abnormalities in cystic fibrosis suggest a deficiency in proteolysis of cholecystokinin. Gosden CM; Gosden JR Lancet; 1984 Sep; 2(8402):541-6. PubMed ID: 6147603 [TBL] [Abstract][Full Text] [Related]
7. [Investigation of pancreas and gallbladder function in children. II. Results in patients with celiac disease, cystic fibrosis of the pancreas and exocrine pancreas insufficiency (author's transl)]. Niessen KH; Osswald P; Brügmann G; Hartmann F; Droste E; Schmidt K Z Kinderheilkd; 1974; 116(4):291-304. PubMed ID: 4825920 [No Abstract] [Full Text] [Related]
8. Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption. Weizman Z; Durie PR; Kopelman HR; Vesely SM; Forstner GG Gut; 1986 Sep; 27(9):1043-8. PubMed ID: 3758817 [TBL] [Abstract][Full Text] [Related]
9. Secretin pancreozymin stimulation test and confirmation of the diagnosis of cystic fibrosis. Wong LT; Turtle S; Davidson AG Gut; 1982 Sep; 23(9):744-50. PubMed ID: 7106621 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. Kopelman H; Durie P; Gaskin K; Weizman Z; Forstner G N Engl J Med; 1985 Feb; 312(6):329-34. PubMed ID: 3969086 [TBL] [Abstract][Full Text] [Related]
11. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation. Al-Mendalawi MD; Abdul-Wahab A; Janahi IA; Abdel-Rahman MO Saudi Med J; 2010 Mar; 31(3):339-40; author reply 340. PubMed ID: 20231949 [No Abstract] [Full Text] [Related]
12. [Release of pancreatic polypeptide after administration of cholecystokinin in children with mucoviscidosis]. Cichy W; Socha J; Barra E Pediatr Pol; 1985 Jun; 60(6):440-4. PubMed ID: 4069838 [No Abstract] [Full Text] [Related]
13. Cystic fibrosis transmembrane conductance regulator protein: what is its role in cystic fibrosis? Richardson PS; Alton EW Eur Respir J; 1993 Feb; 6(2):160-2. PubMed ID: 7680321 [No Abstract] [Full Text] [Related]
14. Disposition of drugs in cystic fibrosis. III. Acetaminophen. Hutabarat RM; Unadkat JD; Kushmerick P; Aitken ML; Slattery JT; Smith AL Clin Pharmacol Ther; 1991 Dec; 50(6):695-701. PubMed ID: 1752114 [TBL] [Abstract][Full Text] [Related]
15. [Study of exocrine pancreatic function in mucoviscidosis]. Hermier M; Mathieu M; Fillat M; Gilly R; Chazalette JP; Cotte J Rev Fr Etud Clin Biol; 1969 Nov; 14(9):867-84. PubMed ID: 5365726 [No Abstract] [Full Text] [Related]
16. What can we learn about fertilization from cystic fibrosis? Florman HM; Jungnickel MK; Sutton KA Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11123-4. PubMed ID: 17595298 [No Abstract] [Full Text] [Related]
17. [The role of apoptosis in induction ocular changes in patients with cystic fibrosis]. Mrugacz M; Zelazowska-Rutkowska B; Bakunowicz-Lazarczyk A; Wysocka J; Kaczmarski M Klin Oczna; 2007; 109(1-3):22-4. PubMed ID: 17687907 [TBL] [Abstract][Full Text] [Related]
18. Determinants of energy utilization in patients with cystic fibrosis. Nutr Rev; 1992 Jul; 50(7):202-3. PubMed ID: 1641201 [TBL] [Abstract][Full Text] [Related]
19. Yet another role for the cystic fibrosis transmembrane conductance regulator. Widdicombe JH Am J Respir Cell Mol Biol; 2000 Jan; 22(1):11-4. PubMed ID: 10615060 [No Abstract] [Full Text] [Related]